Title: Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.
Journal: Analytical chemistry 20120320
Title: Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
Journal: Bioconjugate chemistry 20111019
Title: Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection.
Journal: Cancer research 20090315
Title: A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Journal: Cancer research 20081115
Title: Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.
Journal: Bioconjugate chemistry 20080801
Title: Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16(9):2562-70.
Title: Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12020-4.
Title: Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics.
Title: Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17(1):114-24.
